Clinical Trial Update: Surrogate Markers for Sudden Cardiac Death in Patients With Diabetes Mellitus and End Stage Renal Disease [NA]

View source ↗

Summary

Update on a completed clinical trial examining surrogate markers for sudden cardiac death in patients with type 2 diabetes mellitus and end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: RWTH Aachen University | Conditions: Diabetes Mellitus Type 2, End Stage Renal Disease | NA | Status: COMPLETED